Level Chart

Basic Info

Boston Scientific Corp (BSX) - Cardiovascular Organic Revenue Growth is at 24.60%, compared to 19.00% last quarter and 10.60% last year. This is higher than the long term average of 10.26%.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 24.60%
Latest Period Sep 2024
Last Updated Oct 31 2024, 08:51 EDT
Next Release Jan 31 2025, 08:30 EST (E)
Long Term Average 10.26%
Average Growth Rate 291.9%
Value from Last Quarter 19.00%
Change from Last Quarter 29.47%
Value from 1 Year Ago 10.60%
Change from 1 Year Ago 132.1%
Frequency Quarterly
Unit Percent
Adjustment N/A

Historical Data

View and export this data back to 2019. Upgrade now.
Date Value
September 30, 2024 24.60%
June 30, 2024 19.00%
March 31, 2024 16.30%
December 31, 2023 13.30%
September 30, 2023 10.60%
June 30, 2023 13.40%
March 31, 2023 14.40%
December 31, 2022 9.40%
September 30, 2022 12.60%
June 30, 2022 7.80%
Date Value
March 31, 2022 10.80%
December 31, 2021 27.00%
September 30, 2021 18.50%
June 30, 2021 43.90%
March 31, 2021 5.40%
December 31, 2020 -13.50%
September 30, 2020 -10.40%
June 30, 2020 -25.30%
March 31, 2020 -2.50%
December 31, 2019 10.00%

Basic Info

Boston Scientific Corp (BSX) - Cardiovascular Organic Revenue Growth is at 24.60%, compared to 19.00% last quarter and 10.60% last year. This is higher than the long term average of 10.26%.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 24.60%
Latest Period Sep 2024
Last Updated Oct 31 2024, 08:51 EDT
Next Release Jan 31 2025, 08:30 EST (E)
Long Term Average 10.26%
Average Growth Rate 291.9%
Value from Last Quarter 19.00%
Change from Last Quarter 29.47%
Value from 1 Year Ago 10.60%
Change from 1 Year Ago 132.1%
Frequency Quarterly
Unit Percent
Adjustment N/A

Related Securities

Symbol Name Change %
BSX Boston Scientific Corp 1.48%